Panagiotopoulos, Alexandros http://orcid.org/0000-0003-3612-9394
Koutsianas, Christos http://orcid.org/0000-0002-6621-6918
Kougkas, Nikolaos http://orcid.org/0000-0001-5275-8639
Moschou, Dimitra
Bournia, Vasiliki-Kalliopi http://orcid.org/0000-0002-2162-1362
Gazi, Sousana http://orcid.org/0000-0002-3151-2055
Tektonidou, Maria G. http://orcid.org/0000-0003-2238-0975
Vassilopoulos, Dimitrios http://orcid.org/0000-0003-2288-3863
Sfikakis, Petros P. http://orcid.org/0000-0001-5484-2930
Fragoulis, George E. http://orcid.org/0000-0003-4932-7023
Article History
Received: 18 January 2023
Accepted: 15 February 2023
First Online: 25 February 2023
Declarations
:
: A. Panagiotopoulos, speaker fees/honoraria: none, C. Koutsianas, speaker fees/honoraria: Abbvie, Pfizer, UCB, Novartis, Aenorasis, Eli-Lilly, Genesis—Pharma, N. Kougkas, speaker fees/honoraria: Abbvie, Pfizer, UCB, Novartis, Aenorasis, UCB, Eli-Lilly, Roche, Genesis, Viatris, MSD, D. Moschou, speaker fees/honoraria: none, V-K Bournia, speaker fees/honoraria: Abbvie, Vianex, S. Gazi, speaker fees/honoraria: none, M.G Tektonidou, speaker fees/honoraria: Genesis—Pharma, UCB, GlaxoSmithKline, MSD, Novartis, Faran, D. Vassilopoulos, speaker fees/honoraria: Abbvie, Aenorasis, Amgen, Boehringer Ingelheim, Janssen, Genesis—Pharma, GSK, MSD, Pfizer, Roche, Sobi, UCB, Eli-Lilly, P.P Sfikakis, speaker fees/honoraria: Actelion, Pfizer, Genesis—Pharma, MSD, UCB, Boehringer Ingelheim, Aenorasis, Gilead, Abbvie, Novartis, Eli-Lilly, G.E Fragoulis, speaker fees/honoraria: Abbvie, Pfizer, UCB, Novartis, Aenorasis, UCB, Janssen, Eli-Lilly.